Status
Conditions
Treatments
About
The investigators hypothesized that using new intravenous infusion pump of patient-controlled analgesia (parecoxib sodium 1 mg/mL + normal saline) would significantly improve postoperative pain control compare to conventional intravenous infusion pump of patient-controlled analgesia (fentanyl citrate 20 mg/mL/kg + ondansetron hydrochloride 16 mg/8 mL + normal saline). This prospective randomized controlled trial was designed to evaluate the benefit of new intravenous infusion pump of patient-controlled analgesia (parecoxib sodium 1 mg/mL + normal saline) for postoperative analgesia after laparotomic liver resection.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patients need laparotomic liver resection.
Exclusion criteria
Patients with contraindications to spinal anesthesia or intrathecal morphine, difficulty understanding passive cutaneous anaphylaxis, a history of drug dependence or chronic pain, body mass index greater than 35 kg/m2, or history of sleep apnea were excluded from this study.
Primary purpose
Allocation
Interventional model
Masking
80 participants in 3 patient groups
Loading...
Central trial contact
Jiabei Wang, PhD; Lianxin Liu, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal